Max Scherzer is back on the injured list. The Toronto Blue Jays placed the 41-year-old future Hall of Famer on the 15-day IL on Monday with right forearm tendinitis and left ankle inflammation. The Jays just lost a key piece of a rotation that was already thin on reliable options.
The forearm tendinitis is the concerning part. Pitcher forearm issues have a way of becoming elbow issues, and elbow issues at age 41 generally do not end well. Scherzer has fought through injury problems for years, but the recovery time between issues has gotten longer and the productive windows shorter.
For the Blue Jays, this is a problem with downstream effects. Toronto signed Scherzer last offseason specifically to be a veteran anchor for a rotation that needed leadership and innings. He has provided some of both when healthy. The healthy stretches have just been increasingly rare.
Across his time with the Jays, Scherzer has made it through a full month of starts only once. The pattern has been a few good outings, then an injury, then a return, then another short stretch of effectiveness, then another setback. The Blue Jays got into this knowing what the deal was. That does not make it any less frustrating.
The rotation now leans more heavily on Kevin Gausman, Jose Berrios, and Chris Bassitt. That is a group that should be enough to keep Toronto competitive, but it is also a group that has its own injury history and inconsistency issues. The bullpen is going to be asked to cover more innings than the team would like.
The bigger picture for the Jays is concerning. Toronto entered the season as a playoff hopeful, with Vladimir Guerrero Jr. signed long-term and a core that should be entering its prime. The team has been treading water for two months. The pitching staff has not generated the upside the front office expected.
Now Scherzer goes back on the shelf, with no real timeline beyond the standard 15-day IL designation. Forearm issues can resolve in two weeks. They can also linger for months. The Blue Jays will not know what they are dealing with until Scherzer ramps back up.
For Scherzer himself, the situation is delicate. He has reached the stage of his career where every injury raises legitimate questions about whether he should keep playing. He has the Cooperstown plaque already locked in. He has earned over $300 million in his career. He has the freedom to walk away at any point.
The competitive drive that made Scherzer great is also what keeps him going through the injury cycles. The same player who pitched through a broken nose in 2019 is the player who keeps coming back from forearm issues in 2026. That is admirable in some ways. It is also painful to watch.
What the Blue Jays need now is clarity. If Scherzer is coming back in two weeks at full strength, the situation is manageable. If he is going to be in and out of the rotation for the rest of the season, Toronto’s front office has decisions to make about how to fill the innings void at the trade deadline.
The trade market for starting pitching is going to be expensive. Tarik Skubal is at the top of the list. The Blue Jays were already going to be in the mix for available arms. Scherzer’s setback might force them to be more aggressive than they wanted to be.
Toronto is at a crossroads. The next few weeks will tell whether this is a contending team trying to fill in around the edges or a fringe playoff team trying to figure out how to stay relevant. Scherzer’s health has more to do with that answer than anyone wants to admit.
A longtime sports reporter, Carlos Garcia has written about some of the biggest and most notable athletic events of the last 5 years. He has been credentialed to cover MLS, NBA and MLB games all over the United States. His work has been published on Fox Sports, Bleacher Report, AOL and the Washington Post.
